PDPN and melanoma: Although the immunomodulatory effects of CAFs are predominantly immunosuppressive and tumour-promoting, in melanoma a podoplanin (PDPN)+, FAP- CAF subtype has been shown to act in an immunostimulatory manner via development of tumour-associated tertiary lymphoid structures (TA-TLS).